Материалов:
1 005 012

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 61

Страница 1 из 7

Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer
), diseases that have no effective therapy. Here, we show that ARID1A mutation confers sensitivity to pan-HDAC
Diaryl Pyrazoline, 1,3,4-Oxadizole, and 1,2,4-Triazole Pharmacophore Hybridization: Design, Synthesis, HDAC Inhibition, and Caspase 3/7 Activation Studies
Alzahrani A.Y.A., Gupta P., Patil V., Meyer-Almes F.-J., Sokolova D.V., Pokrovsky V.S., Ramaa C.S.
characterized. The compounds were tested for HDAC inhibitory properties on HDAC4 and HDAC8 isoforms, with a
Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes
Kozlov M., Kleymenova A., Konduktorov K., Malikova A., Kochetkov S.
of selective inhibitors of histone deacetylases HDAC6 and SIRT-2 - tubastatin A and 2-(3-phenethoxyphenylamino
Immunohistochemical Analysis of Epigenetic Markers in Cervical Pathologies Associated with Human Papillomavirus Infection
Kogan E., Unanyan A., Kadyrova A., Demura T., Sidorova I., Faizullin R., Ischenko A.
. Immunohistochemical features analyzed included histone deacetylases (HDAC1, HDAC2) and DNA methyltransferases (DNMT1
Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes
Kozlov M., Kleymenova A., Konduktorov K., Malikova A., Kochetkov S.
of selective inhibitors of histone deacetylases HDAC6 and SIRT-2 - tubastatin A and 2-(3-phenethoxyphenylamino
Immunohistochemical Analysis of Epigenetic Markers in Cervical Pathologies Associated with Human Papillomavirus Infection
Kogan E., Unanyan A., Kadyrova A., Demura T., Sidorova I., Faizullin R., Ischenko A.
. Immunohistochemical features analyzed included histone deacetylases (HDAC1, HDAC2) and DNA methyltransferases (DNMT1
Nortriptyline overcomes corticosteroid resistance in NK and NKT-like cells from peripheral blood of patients with chronic obstructive pulmonary disease
Kadushkin, A. G., Tahanovich, A. D., Movchan, L. V., Dziadzichkina, V. V., Levandovskaya, O. V.
HDAC2
Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation
Chistiakov Dimitry A.
such as DNA methyltransferases (DNMTs), histone acetyltransferases, histone deacetylases (HDACs), etc. may
Epigenetic effects of enzastaurin – a new aspect in the mechanism of action of an anticancer drug from protein kinase inhibitors
Maksimova V.P., Makus J.V., Usalka O.G., Lylova E.S., Bugaeva P.E., Zhidkova E.M., Fedorov D.A., Lizogub O.P., Lesovaya E.A., Belitsky G.A., Yakubovskaya M.G., Kirsanov K.I.
; 3) activity of HAT and HDAC1 enzymes; 4) expression levels of the genes encoding epigenetic
Epigenetic effects of enzastaurin - a new aspect in the mechanism of action of an anticancer drug from protein kinase inhibitors
Maksimova V.P., Makus J.V., Usalka O.G., Lylova E.S., Bugaeva P.E., Zhidkova E.M., Fedorov D.A., Lizogub O.P., Lesovaya E.A., Belitsky G.A., Yakubovskaya M.G., Kirsanov K.I.
; 3) activity of HAT and HDAC1 enzymes; 4) expression levels of the genes encoding epigenetic

Страница 1 из 7

Фасеты

Новости проекта

Новости

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core